486 related articles for article (PubMed ID: 31060525)
1. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
3. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
Wang Q; Qin J; Chen A; Zhou J; Liu J; Cheng J; Qiu J; Zhang J
Tumour Biol; 2015 May; 36(5):3703-8. PubMed ID: 25560490
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
[TBL] [Abstract][Full Text] [Related]
12. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
13. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
Wang C; Jiang T
Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of miR-20a and miR-203 in cervical cancer.
Zhao S; Yao DS; Chen JY; Ding N
Asian Pac J Cancer Prev; 2013; 14(4):2289-93. PubMed ID: 23725129
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
20. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
